{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:07:05Z","timestamp":1790417225970,"version":"4.1.0"},"reference-count":211,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.4065\/80.12.1660","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:26:10Z","timestamp":1232760370000},"page":"1660-1674","source":"Crossref","is-referenced-by-count":27,"title":["Chronic Lymphoid Leukemias Other Than Chronic Lymphocytic Leukemia: Diagnosis and Treatment"],"prefix":"10.4065","volume":"80","author":[{"given":"Farhad","family":"Ravandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/80.12.1660_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(73)93135-8","article-title":"Prolymphocytic leukaemia of B and T cell type","volume":"2","author":"Catovsky","year":"1973","journal-title":"Lancet"},{"key":"10.4065\/80.12.1660_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1974.tb06769.x","article-title":"Prolymphocytic leukaemia","volume":"27","author":"Galton","year":"1974","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib3","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"131","article-title":"B-cell prolymphocytic leukaemia","author":"Catovsky","year":"2001"},{"key":"10.4065\/80.12.1660_bib4","series-title":"Chronic Lymphoid Leukemias","first-page":"525","article-title":"Prolymphocytic leukemia of B- and T-cell types","author":"Matutes","year":"2001"},{"key":"10.4065\/80.12.1660_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/10428190109097717","article-title":"A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive forms","volume":"42","author":"Hercher","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/80.12.1660_bib6","first-page":"27","article-title":"Cytogenetic studies on prolymphocytic leukemia, 1: B-cell prolymphocytic leukemia","volume":"1","author":"Brito-Babapulle","year":"1987","journal-title":"Hematol Pathol"},{"key":"10.4065\/80.12.1660_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/gcc.2870050210","article-title":"Translocation t(11;14)(q13;q32) in chronic lymphoid disorders","volume":"5","author":"Brito-Babapulle","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/80.12.1660_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2141.2004.04913.x","article-title":"B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia","volume":"125","author":"Ruchlemer","year":"2004","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2401644","article-title":"Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL)","volume":"14","author":"Lens","year":"2000","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib10","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood.V89.6.2015","article-title":"p53 abnormalities in B-cell prolymphocytic leukemia","volume":"89","author":"Lens","year":"1997","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib11","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.4065\/80.12.1660_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/10428199909093739","article-title":"B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course","volume":"33","author":"Shvidel","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/80.12.1660_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ijc.2910270309","article-title":"Spontaneous cytogenetic abnormalities in lymphocytes from thirteen patients with ataxia telangiectasia","volume":"27","author":"Taylor","year":"1981","journal-title":"Int J Cancer"},{"key":"10.4065\/80.12.1660_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1200\/JCO.1997.15.1.37","article-title":"Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia","volume":"15","author":"Saven","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0002-9343(91)80164-H","article-title":"Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia","volume":"90","author":"Kantarjian","year":"1991","journal-title":"Am J Med"},{"key":"10.4065\/80.12.1660_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/bjc.1990.217","article-title":"Deoxycoformycin in the treatment of mature B-cell malignancies","volume":"62","author":"Dearden","year":"1990","journal-title":"Br J Cancer"},{"key":"10.4065\/80.12.1660_bib17","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jnci\/85.8.658","article-title":"Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group","volume":"85","author":"Dohner","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.4065\/80.12.1660_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000040977","article-title":"Rituximab (anti-CD20 monoclonal antibody) administration in a young patient with resistant B-prolymphocytic leukemia","volume":"102","author":"Vartholomatos","year":"1999","journal-title":"Acta Haematol"},{"key":"10.4065\/80.12.1660_bib19","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2001.19.8.2165","article-title":"Rituximab dose-escalation trial in chronic lymphocytic leukemia","volume":"19","author":"O'Brien","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib20","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.2001.19.8.2153","article-title":"Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity","volume":"19","author":"Byrd","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib21","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1200\/JCO.2005.12.051","article-title":"Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia","volume":"23","author":"Keating","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib22","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1200\/JCO.2005.12.516","article-title":"Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia","volume":"23","author":"Wierda","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2141.1997.d01-2061.x","article-title":"Subcutaneous CAMPATH-1H in fludarabine-resistant\/relapsed chronic lymphocytic and B-prolymphocytic leukaemia","volume":"96","author":"Bowen","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib24","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580","article-title":"p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias","volume":"85","author":"Dohner","year":"1995","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM200208083470619","article-title":"Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy [letter]","volume":"347","author":"Stilgenbauer","year":"2002","journal-title":"N Engl J Med"},{"key":"10.4065\/80.12.1660_bib26","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1182\/blood-2003-10-3729","article-title":"Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions","volume":"103","author":"Lozanski","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib27","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood-2002-07-1952","article-title":"Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies","volume":"101","author":"Faderl","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib28","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","article-title":"Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib29","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"138","article-title":"Hairy cell leukaemia","author":"Foucar","year":"2001"},{"key":"10.4065\/80.12.1660_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1521-6926(02)00086-5","article-title":"The variant form of hairy-cell leukaemia","volume":"16","author":"Matutes","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/80.12.1660_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1521-6926(02)00087-7","article-title":"Pathology of hairy-cell leukaemia","volume":"16","author":"Bethel","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/80.12.1660_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/blood.V53.3.412.412","article-title":"Leukemic reticuloendotheliosis (hairy cell leukemia)","volume":"53","author":"Bouroncle","year":"1979","journal-title":"Blood"},{"issue":"5, pt 1","key":"10.4065\/80.12.1660_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-89-5-677","article-title":"Hairy cell leukemia: a clinical review based on 71 cases","volume":"89","author":"Golomb","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.4065\/80.12.1660_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1521-6926(02)00085-3","article-title":"Clinical manifestations and infectious complications of hairy-cell leukaemia","volume":"16","author":"Kraut","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/80.12.1660_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ajcp\/108.3.308","article-title":"Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders","volume":"108","author":"Hoyer","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/80.12.1660_bib36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.pas.0000155152.56736.06","article-title":"High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia","volume":"29","author":"Went","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.4065\/80.12.1660_bib37","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(04)16356-3","article-title":"Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1) [published correction appears in Lancet. 2004;363:2194]","volume":"363","author":"Falini","year":"2004","journal-title":"Lancet"},{"key":"10.4065\/80.12.1660_bib38","first-page":"362","article-title":"Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia","volume":"11","author":"Catovsky","year":"1984","journal-title":"Semin Oncol"},{"key":"10.4065\/80.12.1660_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V76.1.157.157","article-title":"A variant form of hairy cell leukemia resistant to \u03b1-interferon: clinical and phenotypic characteristics of 17 patients","volume":"76","author":"Sainati","year":"1990","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1309\/8QYTYQ1CLQMHQ9CL","article-title":"Hairy cell leukemia variant: fact or fiction","volume":"123","author":"Cessna","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/80.12.1660_bib41","first-page":"384","article-title":"Differentiating atypical HCL from HCL-Japanese variant [letter]","volume":"10","author":"Kondo","year":"1996","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib42","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V52.6.1132.1132","article-title":"Multiple heavy chain isotypes on the surface of the cells of hairy cell leukemia","volume":"52","author":"Burns","year":"1978","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib43","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V75.4.972.972","article-title":"Hairy cell leukemia preferentially expresses the IgG3-subclass","volume":"75","author":"Kluin-Nelemans","year":"1990","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib44","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood.V98.4.1174","article-title":"Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing","volume":"98","author":"Forconi","year":"2001","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib45","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1182\/blood-2004-03-0950","article-title":"Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch","volume":"104","author":"Forconi","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib46","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/sj.leu.2403503","article-title":"VH gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin [letter]","volume":"18","author":"Vanhentenrijk","year":"2004","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.leukres.2004.05.016","article-title":"Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia","volume":"29","author":"Thorselius","year":"2005","journal-title":"Leuk Res"},{"key":"10.4065\/80.12.1660_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20031175","article-title":"Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors","volume":"199","author":"Basso","year":"2004","journal-title":"J Exp Med"},{"key":"10.4065\/80.12.1660_bib49","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.V82.4.1277.1277","article-title":"Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia","volume":"82","author":"Robbins","year":"1993","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jcp.51.5.364","article-title":"Levels of expression of CD19 and CD20 in chronic B cell leukaemias","volume":"51","author":"Ginaldi","year":"1998","journal-title":"J Clin Pathol"},{"key":"10.4065\/80.12.1660_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.10428","article-title":"CD52 expression in hairy cell leukemia","volume":"74","author":"Quigley","year":"2003","journal-title":"Am J Hematol"},{"key":"10.4065\/80.12.1660_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0165-4608(01)00448-4","article-title":"Clonal chromosome rearrangements in hairy cell leukemia: personal experience and review of literature","volume":"129","author":"Sambani","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.4065\/80.12.1660_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1521-6926(02)00082-8","article-title":"The biology of hairy cells","volume":"16","author":"Zuzel","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/80.12.1660_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/geno.1999.5911","article-title":"Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates","volume":"60","author":"Wu","year":"1999","journal-title":"Genomics"},{"key":"10.4065\/80.12.1660_bib55","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0145-2126(99)00127-7","article-title":"p53 gene deletion and trisomy 12 in hairy cell leukemia and its variant","volume":"23","author":"Vallianatou","year":"1999","journal-title":"Leuk Res"},{"key":"10.4065\/80.12.1660_bib56","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.leu.2401721","article-title":"p53 mutations in hairy cell leukemia","volume":"14","author":"Konig","year":"2000","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1521-6926(02)00083-X","article-title":"Splenectomy and treatments of historical interest","volume":"16","author":"Zakarija","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/80.12.1660_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198401053100104","article-title":"Alpha interferon for induction of remission in hairy-cell leukemia","volume":"310","author":"Quesada","year":"1984","journal-title":"N Engl J Med"},{"key":"10.4065\/80.12.1660_bib59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jnci\/80.5.369","article-title":"Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia","volume":"80","author":"Golomb","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.4065\/80.12.1660_bib60","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood.V75.4.839.839","article-title":"Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a","volume":"75","author":"Berman","year":"1990","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1521-6926(02)00089-0","article-title":"Cladribine in the treatment of hairy-cell leukaemia","volume":"16","author":"Goodman","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/80.12.1660_bib62","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.1998.16.9.3007","article-title":"Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients","volume":"16","author":"Cheson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib63","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1182\/blood.V92.6.1918","article-title":"Long-term follow-up of patients with hairy cell leukemia after cladribine treatment","volume":"92","author":"Saven","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib64","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1200\/JCO.2003.05.093","article-title":"Extended follow-up of patients with hairy cell leukemia after treatment with cladribine","volume":"21","author":"Goodman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib65","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V88.6.1954.bloodjournal8861954","article-title":"Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the North-western University experience","volume":"88","author":"Tallman","year":"1996","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood-2005-01-0173","article-title":"Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience","volume":"106","author":"Chadha","year":"2005","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib67","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1200\/JCO.1997.15.3.1138","article-title":"Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up","volume":"15","author":"Hoffman","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib68","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood.V79.4.882.bloodjournal794882","article-title":"Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)","volume":"79","author":"Estey","year":"1992","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib69","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2141.1999.01546.x","article-title":"Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine","volume":"106","author":"Dearden","year":"1999","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib70","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.V79.4.888.bloodjournal794888","article-title":"Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2\u2032-deoxyadenosine (CdA): relation to opportunistic infections","volume":"79","author":"Juliusson","year":"1992","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib71","first-page":"309","article-title":"Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine","volume":"89","author":"Zinzani","year":"2004","journal-title":"Haematologica"},{"key":"10.4065\/80.12.1660_bib72","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/sj.leu.2403418","article-title":"An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine","volume":"18","author":"Jehn","year":"2004","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib73","doi-asserted-by":"crossref","first-page":"946a","DOI":"10.1182\/blood.V104.11.3473.3473","article-title":"Long term follow-up of patients with hairy cell leukemia (HCL) [abstract]","volume":"104","author":"Ravandi-Kashani","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1521-6926(03)00002-1","article-title":"Pentostatin in the treatment of hairy-cell leukemia","volume":"16","author":"Grever","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/80.12.1660_bib75","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1200\/JCO.1989.7.2.168","article-title":"Pentostatin in the treatment of advanced hairy cell leukemia","volume":"7","author":"Kraut","year":"1989","journal-title":"J Clin Oncol"},{"issue":"2, suppl","key":"10.4065\/80.12.1660_bib76","first-page":"32","article-title":"Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study","volume":"27","author":"Johnston","year":"2000","journal-title":"Semin Oncol"},{"issue":"suppl 1","key":"10.4065\/80.12.1660_bib77","first-page":"109","article-title":"Long term results with 2\u2032deoxycoformycin in hairy cell leukemia","volume":"14","author":"Catovsky","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/80.12.1660_bib78","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.1995.13.4.974","article-title":"Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study","volume":"13","author":"Grever","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib79","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<352::AID-CNCR15>3.0.CO;2-8","article-title":"Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients","volume":"88","author":"Rafel","year":"2000","journal-title":"Cancer"},{"key":"10.4065\/80.12.1660_bib80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<65::AID-CNCR9>3.0.CO;2-B","article-title":"Long term outcome of patients with hairy cell leukemia treated with pentostatin","volume":"85","author":"Ribeiro","year":"1999","journal-title":"Cancer"},{"key":"10.4065\/80.12.1660_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.leu.2402784","article-title":"Long-term outcome with pentostatin treatment in hairy cell leukemia patients: a French retrospective study of 238 patients","volume":"17","author":"Maloisel","year":"2003","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib82","doi-asserted-by":"crossref","first-page":"946a","DOI":"10.1182\/blood.V104.11.3472.3472","article-title":"Pentostatin and cladribine in hairy cell leukemia\u2014a retrospective comparison of a large series with long follow up [abstract]","volume":"104","author":"Else","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib83","first-page":"2981","article-title":"Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin","volume":"96","author":"Flinn","year":"2000","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib84","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V87.4.1556.bloodjournal8741556","article-title":"Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine","volume":"87","author":"Wheaton","year":"1996","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/G6299513NGLCUB1K","article-title":"Minimal residual disease detection in hairy cell leukemia: comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene","volume":"119","author":"Sausville","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/80.12.1660_bib86","first-page":"1046","article-title":"Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia","volume":"86","author":"Lauria","year":"2001","journal-title":"Haematologica"},{"key":"10.4065\/80.12.1660_bib87","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1365-2141.2001.03143.x","article-title":"Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia","volume":"115","author":"Hagberg","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib88","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood-2003-01-0014","article-title":"Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia","volume":"102","author":"Nieva","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib89","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1182\/blood-2003-02-0630","article-title":"Rituximab in relapsed or refractory hairy cell leukemia","volume":"102","author":"Thomas","year":"2003","journal-title":"Blood"},{"issue":"suppl","key":"10.4065\/80.12.1660_bib90","first-page":"590s","article-title":"Phase II study of cladribine (2CDA) followed by rituximab for eradication of minimal residual disease (MRD) in hairy cell leukemia (HCL) [abstract]","volume":"23","author":"Ravandi-Kashani","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib91","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM200107263450402","article-title":"Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia","volume":"345","author":"Kreitman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4065\/80.12.1660_bib92","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.thj.6200373","article-title":"Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment [letter]","volume":"5","author":"Fietz","year":"2004","journal-title":"Hematol J"},{"key":"10.4065\/80.12.1660_bib93","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"195","article-title":"T-cell prolymphocytic leukaemia","author":"Catovsky","year":"2001"},{"key":"10.4065\/80.12.1660_bib94","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood.V78.12.3269.3269","article-title":"Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia","volume":"78","author":"Matutes","year":"1991","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib95","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1309\/93P42RNG5XBG3KBE","article-title":"T-cell prolymphocytic leukemia involving extramedullary sites","volume":"123","author":"Valbuena","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/80.12.1660_bib96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.1986.tb07579.x","article-title":"The morphological spectrum of T-prolymphocytic leukaemia","volume":"64","author":"Matutes","year":"1986","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib97","first-page":"262","article-title":"Sezary cell-like leukemia: a distinct type of mature T cell malignancy [published correction appears in Leukemia. 1990;4:547]","volume":"4","author":"Matutes","year":"1990","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib98","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1365-2141.1997.9702605.x","article-title":"Relationship of T leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia: a cytogenetic analysis with in situ hybridization","volume":"96","author":"Brito-Babapulle","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib99","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.leu.2400725","article-title":"The human T-cell lymphotropic viruses types I\/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia","volume":"11","author":"Pawson","year":"1997","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ijc.2910600617","article-title":"T-cell malignancies in Brazil: clinico-pathological and molecular studies of HTLV-I-positive and -negative cases","volume":"60","author":"Pombo de Oliveira","year":"1995","journal-title":"Int J Cancer"},{"key":"10.4065\/80.12.1660_bib101","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1046\/j.1365-2141.1996.d01-1720.x","article-title":"Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry","volume":"93","author":"Ginaldi","year":"1996","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib102","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2141.1998.00977.x","article-title":"Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia","volume":"103","author":"Garand","year":"1998","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib103","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(87)90552-6","article-title":"Role of chromosome translocations in human neoplasia","volume":"49","author":"Croce","year":"1987","journal-title":"Cell"},{"key":"10.4065\/80.12.1660_bib104","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1126\/science.3919442","article-title":"Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms","volume":"227","author":"Croce","year":"1985","journal-title":"Science"},{"key":"10.4065\/80.12.1660_bib105","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood.V70.4.926.926","article-title":"Cytogenetic studies on prolymphocytic leukemia, II: T cell prolymphocytic leukemia","volume":"70","author":"Brito-Babapulle","year":"1987","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib106","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1073\/pnas.91.26.12530","article-title":"Identification of the TCL1 gene involved in T-cell malignancies","volume":"91","author":"Virgilio","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.12.1660_bib107","first-page":"5452","article-title":"TCL1 is overexpressed in patients affected by adult T-cell leukemias","volume":"57","author":"Narducci","year":"1997","journal-title":"Cancer Res"},{"key":"10.4065\/80.12.1660_bib108","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1073\/pnas.86.2.602","article-title":"Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient","volume":"86","author":"Russo","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.12.1660_bib109","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1073\/pnas.90.20.9275","article-title":"Chromosome walking on the TCL1 locus involved in T-cell neoplasia","volume":"90","author":"Virgilio","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.12.1660_bib110","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1038\/sj.onc.1204596","article-title":"The role of TCL1 in human T-cell leukemia","volume":"20","author":"Pekarsky","year":"2001","journal-title":"Oncogene"},{"key":"10.4065\/80.12.1660_bib111","first-page":"2475","article-title":"MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha\/delta locus in mature T cell proliferations","volume":"8","author":"Stern","year":"1993","journal-title":"Oncogene"},{"key":"10.4065\/80.12.1660_bib112","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood.V87.5.1923.1923","article-title":"Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations","volume":"87","author":"Madani","year":"1996","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib113","doi-asserted-by":"crossref","first-page":"14418","DOI":"10.1073\/pnas.96.25.14418","article-title":"Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes","volume":"96","author":"Hallas","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.12.1660_bib114","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1073\/pnas.96.6.2949","article-title":"Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes","volume":"96","author":"Pekarsky","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.12.1660_bib115","first-page":"2313","article-title":"Identification of the TCL1\/MTCP1-like 1 (TML1) gene from the region next to the TCL1 locus","volume":"59","author":"Sugimoto","year":"1999","journal-title":"Cancer Res"},{"key":"10.4065\/80.12.1660_bib116","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1097-1155","article-title":"Biallelic mutations in the ATM gene in T-prolymphocytic leukemia","volume":"3","author":"Stilgenbauer","year":"1997","journal-title":"Nat Med"},{"key":"10.4065\/80.12.1660_bib117","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1182\/blood.V91.10.3920.3920_3920_3926","article-title":"Inactivation of the ATM gene in T-cell prolymphocytic leukemias","volume":"91","author":"Stoppa-Lyonnet","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib118","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ng0997-96","article-title":"Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia","volume":"17","author":"Vorechovsky","year":"1997","journal-title":"Nat Genet"},{"key":"10.4065\/80.12.1660_bib119","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.1991.423","article-title":"Deoxycoformycin in the treatment of mature T-cell leukaemias","volume":"64","author":"Dearden","year":"1991","journal-title":"Br J Cancer"},{"key":"10.4065\/80.12.1660_bib120","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1200\/JCO.1994.12.12.2588","article-title":"The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype","volume":"12","author":"Mercieca","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib121","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1200\/JCO.1997.15.7.2667","article-title":"Treatment of T-cell prolymphocytic leukemia with human CD52 antibody","volume":"15","author":"Pawson","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib122","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V98.6.1721","article-title":"High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H","volume":"98","author":"Dearden","year":"2001","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib123","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1200\/JCO.20.1.205","article-title":"Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed","volume":"20","author":"Keating","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.12.1660_bib124","first-page":"644a","article-title":"Very high response rates in previously untreated T-cell prolymphocytic leukaemia patients receiving alemtuzumab (Campath-1H) therapy [abstract]","volume":"102","author":"Dearden","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0145-2126(97)00158-6","article-title":"Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H","volume":"22","author":"Ginaldi","year":"1998","journal-title":"Leuk Res"},{"key":"10.4065\/80.12.1660_bib126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-102-2-169","article-title":"Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia","volume":"102","author":"Loughran","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.4065\/80.12.1660_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","article-title":"Clonal diseases of large granular lymphocytes","volume":"82","author":"Loughran","year":"1993","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib128","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"197","article-title":"T-cell large granular lymphocyte leukemia","author":"Chan","year":"2001"},{"key":"10.4065\/80.12.1660_bib129","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V89.1.256","article-title":"The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis","volume":"89","author":"Semenzato","year":"1997","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1634\/theoncologist.9-3-247","article-title":"T-cell large granular lymphocyte leukemia and related disorders","volume":"9","author":"Rose","year":"2004","journal-title":"Oncologist"},{"key":"10.4065\/80.12.1660_bib131","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1182\/blood.V69.6.1786.1786","article-title":"Clinical features in large granular lymphocytic leukemia [letter]","volume":"69","author":"Loughran","year":"1987","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib132","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/1097-0142(19871215)60:12<2971::AID-CNCR2820601220>3.0.CO;2-O","article-title":"The lymphoproliferative disease of granular lymphocytes: a heterogeneous disorder ranging from indolent to aggressive conditions","volume":"60","author":"Semenzato","year":"1987","journal-title":"Cancer"},{"key":"10.4065\/80.12.1660_bib133","first-page":"617","article-title":"Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature","volume":"2","author":"Oshimi","year":"1988","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib134","series-title":"Chronic Lymphoid Leukemias","first-page":"543","article-title":"Chronic T-cell and NK-cell leukemias","author":"Miranda","year":"2001"},{"key":"10.4065\/80.12.1660_bib135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/asheducation-2004.1.63","article-title":"Congenital and acquired neutropenia","author":"Berliner","year":"2004","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.4065\/80.12.1660_bib136","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2141.1997.d01-2113.x","article-title":"Constitutive expression of Fas ligand in large granular lymphocyte leukaemia","volume":"97","author":"Perzova","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib137","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood.V92.12.4771","article-title":"Dysregulation of CD95\/CD95 ligand-apoptotic pathway in CD3+ large granular lymphocyte leukemia","volume":"92","author":"Lamy","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib138","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by Fas ligand","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib139","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9343(77)90422-3","article-title":"Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics","volume":"62","author":"McKenna","year":"1977","journal-title":"Am J Med"},{"key":"10.4065\/80.12.1660_bib140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.0007-1048.2001.03315.x","article-title":"Chromosomal abnormalities in T-cell large granular lymphocyte leukaemia: report of two cases and review of the literature","volume":"116","author":"Wong","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib141","first-page":"782","article-title":"Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders","volume":"7","author":"Oshimi","year":"1993","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.56.1.1","article-title":"Diagnostic role of tests for T cell receptor (TCR) genes","volume":"56","author":"Hodges","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.4065\/80.12.1660_bib143","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)63032-5","article-title":"Immunophenotypic analysis of the TCR-V\u03b2 repertoire in 98 persistent expansions of CD3+\/TCR-\u03b1\u03b2+ large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease","volume":"159","author":"Lima","year":"2001","journal-title":"Am J Pathol"},{"key":"10.4065\/80.12.1660_bib144","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V84.7.2315.2315","article-title":"CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia","volume":"84","author":"Gentile","year":"1994","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib145","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2141.1992.tb06458.x","article-title":"A distinct large granular lymphocyte (LGL)\/NK-associated (NKa) abnormality characterized by membrane CD4 and CD8 coexpression","volume":"82","author":"Richards","year":"1992","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib146","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood.V74.1.285.285","article-title":"Clonal expansion of lymphocytes bearing the gamma delta T-cell receptor in a patient with large granular lymphocyte disorder","volume":"74","author":"Vie","year":"1989","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib147","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2141.2003.04365.x","article-title":"T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition","volume":"121","author":"Dang","year":"2003","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib148","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V84.5.1620.bloodjournal8451620","article-title":"Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?","volume":"84","author":"Dhodapkar","year":"1994","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib149","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2401304","article-title":"Spontaneous remission of large granular lymphocyte T cell leukemia [letter]","volume":"13","author":"Takeuchi","year":"1999","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/1097-0142(19900115)65:2<341::AID-CNCR2820650227>3.0.CO;2-2","article-title":"Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes: a multicenter study","volume":"65","author":"Pandolfi","year":"1990","journal-title":"Cancer"},{"key":"10.4065\/80.12.1660_bib151","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood.V84.8.2721.2721","article-title":"Chronic natural killer cell lymphocytosis: a descriptive clinical study","volume":"84","author":"Tefferi","year":"1994","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib152","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood.V84.7.2164.2164","article-title":"Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate","volume":"84","author":"Loughran","year":"1994","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib153","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood.V91.9.3372","article-title":"Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells","volume":"91","author":"Sood","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib154","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V98.2.483","article-title":"Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes","volume":"98","author":"Go","year":"2001","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib155","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0002-9343(00)00406-X","article-title":"Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis","volume":"108","author":"Hamidou","year":"2000","journal-title":"Am J Med"},{"key":"10.4065\/80.12.1660_bib156","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2141.1996.5061047.x","article-title":"Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis","volume":"93","author":"Bible","year":"1996","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib157","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1182\/blood.V87.7.3000.bloodjournal8773000","article-title":"Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities","volume":"87","author":"Lacy","year":"1996","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib158","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01698137","article-title":"Correction of neutropenia by GM-CSF in patients with a large granular lymphocyte proliferation","volume":"65","author":"Mulder","year":"1992","journal-title":"Ann Hematol"},{"key":"10.4065\/80.12.1660_bib159","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2141.1989.tb06291.x","article-title":"Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF)","volume":"71","author":"Thomssen","year":"1989","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib160","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood.V85.11.3352.bloodjournal85113352","article-title":"Response to granulocyte-macrophage colony-stimulating factor (GM-CSF) but not to G-CSF in a case of agranulocytosis associated with large granular lymphocyte (LGL) leukemia [letter]","volume":"85","author":"Lamy","year":"1995","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib161","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10428199609054846","article-title":"Resolution of autoimmune hemolytic anemia following splenectomy in CD3+ large granular lymphocyte leukemia","volume":"23","author":"Gentile","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/80.12.1660_bib162","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2141.1988.tb02423.x","article-title":"Effect of splenectomy in aggressive large granular lymphocyte leukaemia [letter]","volume":"69","author":"Imamura","year":"1988","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib163","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2141.1987.tb02316.x","article-title":"Evaluation of splenectomy in large granular lymphocyte leukaemia","volume":"67","author":"Loughran","year":"1987","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib164","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2141.1998.00606.x","article-title":"Multidrug resistance analysis in lymphoproliferative disease of large granular lymphocytes","volume":"100","author":"Lamy","year":"1998","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib165","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2141.2003.04148.x","article-title":"Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity","volume":"120","author":"Sternberg","year":"2003","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib166","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V84.3.733.733","article-title":"2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders","volume":"84","author":"O'Brien","year":"1994","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib167","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.2004.04852.x","article-title":"Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients","volume":"124","author":"Ma","year":"2004","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib168","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2141.2003.04609.x","article-title":"Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H)","volume":"123","author":"Ru","year":"2003","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib169","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2003-11-3951","article-title":"Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia [letter]","volume":"103","author":"Rosenblum","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib170","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.12.1660_bib171","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1158\/0008-5472.CAN-05-0559","article-title":"Human T-cell leukemia virus type I at age 25: a progress report","volume":"65","author":"Matsuoka","year":"2005","journal-title":"Cancer Res"},{"key":"10.4065\/80.12.1660_bib172","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","article-title":"Human T cell leukemia virus type I (HTLV-I) and human diseases","volume":"15","author":"Uchiyama","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.4065\/80.12.1660_bib173","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2141.1998.00582.x","article-title":"Management of adult T-cell leukaemia\/lymphoma","volume":"100","author":"Pawson","year":"1998","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib174","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-1702(01)00286-6","article-title":"Treatment of adult T-cell leukaemia\/lymphoma: current strategy and future perspectives","volume":"78","author":"Bazarbachi","year":"2001","journal-title":"Virus Res"},{"key":"10.4065\/80.12.1660_bib175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(94)90994-6","article-title":"Human T-lymphotropic virus type I in Japan","volume":"343","author":"Yamaguchi","year":"1994","journal-title":"Lancet"},{"key":"10.4065\/80.12.1660_bib176","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.2910450206","article-title":"The 4th nation-wide study of adult T-cell leukemia\/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features","volume":"45","author":"Tajima","year":"1990","journal-title":"Int J Cancer"},{"key":"10.4065\/80.12.1660_bib177","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib178","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/1097-0142(19850215)55:4<851::AID-CNCR2820550424>3.0.CO;2-J","article-title":"Variation in the clinical courses of adult T-cell leukemia","volume":"55","author":"Kawano","year":"1985","journal-title":"Cancer"},{"key":"10.4065\/80.12.1660_bib179","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0145-2126(93)90061-O","article-title":"Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia\/lymphoma","volume":"17","author":"Tsukasaki","year":"1993","journal-title":"Leuk Res"},{"issue":"suppl 1","key":"10.4065\/80.12.1660_bib180","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/00042560-199600001-00005","article-title":"Adult T-cell leukemia\/lymphoma in Jamaica: 1986-1995","volume":"13","author":"Hanchard","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.4065\/80.12.1660_bib181","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0145-2126(91)90087-A","article-title":"Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study","volume":"15","author":"Lymphoma Study Group (1984-1987)","year":"1991","journal-title":"Leuk Res"},{"key":"10.4065\/80.12.1660_bib182","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198308043090501","article-title":"Clinical course of retrovirus-associated adult T-cell lymphoma in the United States","volume":"309","author":"Bunn","year":"1983","journal-title":"N Engl J Med"},{"key":"10.4065\/80.12.1660_bib183","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/bmj.297.6661.1456","article-title":"Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant","volume":"297","author":"Pagliuca","year":"1988","journal-title":"BMJ"},{"key":"10.4065\/80.12.1660_bib184","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"200","article-title":"Adult T-cell leukemia\/lymphoma","author":"Catovsky","year":"2001"},{"key":"10.4065\/80.12.1660_bib185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V58.3.645.645","article-title":"Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies","volume":"58","author":"Hattori","year":"1981","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib186","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00320296","article-title":"Adult T-cell leukemia with an unusual phenotype, Leu-2a positive and Leu-3a negative","volume":"50","author":"Amagasaki","year":"1985","journal-title":"Blut"},{"key":"10.4065\/80.12.1660_bib187","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0145-2126(92)90168-7","article-title":"Phenotypic diversity and prognosis of adult T-cell leukemia","volume":"16","author":"Kamihira","year":"1992","journal-title":"Leuk Res"},{"key":"10.4065\/80.12.1660_bib188","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V79.2.477.477","article-title":"Mutations of the p53 gene in adult T-cell leukemia","volume":"79","author":"Sakashita","year":"1992","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib189","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF02986621","article-title":"Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma","volume":"77","author":"Tobinai","year":"2003","journal-title":"Int J Hematol"},{"key":"10.4065\/80.12.1660_bib190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/10428199509059624","article-title":"Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia","volume":"18","author":"Uozumi","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/80.12.1660_bib191","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10428199809057597","article-title":"Adult T-cell leukemia\/lymphoma in London: clinical experience of 21 cases","volume":"31","author":"Pawson","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/80.12.1660_bib192","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood.V81.10.2810.2810","article-title":"Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen","volume":"81","author":"Sparano","year":"1993","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib193","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00042560-199606010-00012","article-title":"An intensive chemotherapy of adult T-cell leukemia\/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support","volume":"12","author":"Taguchi","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.4065\/80.12.1660_bib194","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib195","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2141.1995.tb08399.x","article-title":"Transmission of human T-lymphotrophic virus type 1 by bone marrow transplantation [letter]","volume":"89","author":"Miyoshi","year":"1995","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib196","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1994.tb05040.x","article-title":"Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia","volume":"88","author":"Ljungman","year":"1994","journal-title":"Br J Haematol"},{"key":"10.4065\/80.12.1660_bib197","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.leu.2403682","article-title":"Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma","volume":"19","author":"Fukushima","year":"2005","journal-title":"Leukemia"},{"key":"10.4065\/80.12.1660_bib198","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine","volume":"332","author":"Gill","year":"1995","journal-title":"N Engl J Med"},{"key":"10.4065\/80.12.1660_bib199","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10428190109057927","article-title":"The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia\/lymphoma","volume":"40","author":"White","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/80.12.1660_bib200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.thj.6200195","article-title":"A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma","volume":"3","author":"Hermine","year":"2002","journal-title":"Hematol J"},{"key":"10.4065\/80.12.1660_bib201","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(04)01608-0","article-title":"New therapeutic approaches for adult T-cell leukaemia","volume":"5","author":"Bazarbachi","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.4065\/80.12.1660_bib202","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","article-title":"Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells","volume":"101","author":"Nasr","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib203","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/sj.thj.6200374","article-title":"Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma","volume":"5","author":"Hermine","year":"2004","journal-title":"Hematol J"},{"key":"10.4065\/80.12.1660_bib204","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.onc.1208212","article-title":"Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia\/lymphoma","volume":"24","author":"Nasr","year":"2005","journal-title":"Oncogene"},{"key":"10.4065\/80.12.1660_bib205","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood-2003-11-3967","article-title":"Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants","volume":"104","author":"Mitra-Kaushik","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib206","first-page":"1083","article-title":"Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia","volume":"62","author":"Tan","year":"2002","journal-title":"Cancer Res"},{"key":"10.4065\/80.12.1660_bib207","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1586\/14737140.4.3.369","article-title":"Adult T-cell leukemia: future prophylaxis and immunotherapy","volume":"4","author":"Kannagi","year":"2004","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.4065\/80.12.1660_bib208","first-page":"6453","article-title":"Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H","volume":"63","author":"Zhang","year":"2003","journal-title":"Cancer Res"},{"key":"10.4065\/80.12.1660_bib209","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V82.6.1701.1701","article-title":"The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia","volume":"82","author":"Waldmann","year":"1993","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib210","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","article-title":"Radioimmunotherapy of interleukin-2R\u03b1-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac","volume":"86","author":"Waldmann","year":"1995","journal-title":"Blood"},{"key":"10.4065\/80.12.1660_bib211","article-title":"Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin","author":"Ravandi","year":"2005","journal-title":"Leuk Res"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961161063X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961161063X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T01:19:29Z","timestamp":1589505569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961161063X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":211,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S002561961161063X"],"URL":"https:\/\/doi.org\/10.4065\/80.12.1660","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}